Posted in | News

Magnesium International Confirm Egypt will be the Site for Their New 88000tpy Magnesium Smelter

Dec 17 2004

Related Stories

Magnesium International Limited (MIL) announced today that it has confirmed Egypt as the location for its 88,000 tonne per year magnesium smelter project. The smelter will be owned and operated by a special purpose company called Egyptian Magnesium Company (EMAG) which is currently being established by MIL and Amiral Investments MIL’s partner in Egypt, under Egyptian Investment Laws.

MIL’s Managing Director, Gordon Galt, said today “We have chosen Egypt after an exhaustive study of possible sites worldwide and I am convinced that Egypt will deliver the world’s best combination of the factors which will affect the success of our venture. There is a very pro-development attitude in the Egyptian Government at present and we look forward to making rapid progress with the project from here on.”

For more information on magnesium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback